By Ben Hirschler | Jan 03, 2013 10:09 AM EST
The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat.
By Ben Hirschler | Dec 06, 2012 10:16 AM EST
British health minister announced plans to roll out telehealth to 100,000 people with long-term conditions in 2013 and have 3 million on the system by 2017.
By Ben Hirschler | Nov 14, 2012 09:44 AM EST
Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed.
By Ben Hirschler | Nov 02, 2012 10:30 AM EDT
European officials have approved the Western world's first gene therapy drug in a milestone for the novel medical technology that fixes faulty genes.
By Ben Hirschler | Sep 19, 2012 09:53 AM EDT
Rats fed a lifetime diet of Monsanto's genetically modified corn or exposed to its top-selling weedkiller Roundup suffered tumours and multiple organ damage.
By Ben Hirschler | Aug 30, 2012 10:40 AM EDT
That Europe needs a common patent is patently obvious to Michael Setton, who runs a tiny technology firm in France making wireless sensors that track environmental and biomedical data.
By Ben Hirschler | Aug 29, 2012 09:41 AM EDT
The expiry of patents on profitable heart medicines is soon going to erode one of the main sources of drug company profits, and risky bets on new medicines to replace them may not make up for the lost sales.
By Ben Hirschler | Aug 15, 2012 10:26 AM EDT
Britain has launched a review of the cosmetic surgery industry, which could lead to tighter restrictions on the way companies operate and market their services in the wake of the PIP breast implant scandal.
By Ben Hirschler | Jul 12, 2012 12:36 PM EDT
AstraZeneca Plc has clinched two new deals in neuroscience, underlining the drugmaker's increasing reliance on external projects to refill a sparse pipeline as it tests a new low-cost approach to drug research.